Logo image of ABI.BR

ANHEUSER-BUSCH INBEV SA/NV (ABI.BR) Stock Fundamental Analysis

EBR:ABI - Euronext Brussels - BE0974293251 - Common Stock - Currency: EUR

53.02  +0.58 (+1.11%)

Fundamental Rating

4

Taking everything into account, ABI scores 4 out of 10 in our fundamental rating. ABI was compared to 26 industry peers in the Beverages industry. While ABI is still in line with the averages on profitability rating, there are concerns on its financial health. ABI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ABI was profitable.
In the past year ABI had a positive cash flow from operations.
In the past 5 years ABI has always been profitable.
ABI had a positive operating cash flow in each of the past 5 years.
ABI.BR Yearly Net Income VS EBIT VS OCF VS FCFABI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

The Return On Assets of ABI (2.83%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 7.48%, ABI is in line with its industry, outperforming 57.69% of the companies in the same industry.
ABI has a Return On Invested Capital (6.49%) which is in line with its industry peers.
ABI had an Average Return On Invested Capital over the past 3 years of 6.05%. This is below the industry average of 8.31%.
The last Return On Invested Capital (6.49%) for ABI is above the 3 year average (6.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.83%
ROE 7.48%
ROIC 6.49%
ROA(3y)2.69%
ROA(5y)2.17%
ROE(3y)7.38%
ROE(5y)6.2%
ROIC(3y)6.05%
ROIC(5y)5.66%
ABI.BR Yearly ROA, ROE, ROICABI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ABI has a Profit Margin of 9.80%. This is in the better half of the industry: ABI outperforms 61.54% of its industry peers.
In the last couple of years the Profit Margin of ABI has declined.
With a decent Operating Margin value of 25.87%, ABI is doing good in the industry, outperforming 69.23% of the companies in the same industry.
ABI's Operating Margin has declined in the last couple of years.
ABI's Gross Margin of 55.25% is fine compared to the rest of the industry. ABI outperforms 61.54% of its industry peers.
In the last couple of years the Gross Margin of ABI has declined.
Industry RankSector Rank
OM 25.87%
PM (TTM) 9.8%
GM 55.25%
OM growth 3Y-0.42%
OM growth 5Y-3.7%
PM growth 3Y4.44%
PM growth 5Y-10.98%
GM growth 3Y-1.3%
GM growth 5Y-1.99%
ABI.BR Yearly Profit, Operating, Gross MarginsABI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

ABI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ABI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ABI has more shares outstanding
Compared to 1 year ago, ABI has an improved debt to assets ratio.
ABI.BR Yearly Shares OutstandingABI.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABI.BR Yearly Total Debt VS Total AssetsABI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

ABI has an Altman-Z score of 1.72. This is a bad value and indicates that ABI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ABI (1.72) is worse than 73.08% of its industry peers.
The Debt to FCF ratio of ABI is 6.45, which is on the high side as it means it would take ABI, 6.45 years of fcf income to pay off all of its debts.
ABI has a Debt to FCF ratio of 6.45. This is in the better half of the industry: ABI outperforms 69.23% of its industry peers.
A Debt/Equity ratio of 0.90 indicates that ABI is somewhat dependend on debt financing.
The Debt to Equity ratio of ABI (0.90) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 6.45
Altman-Z 1.72
ROIC/WACC1.09
WACC5.96%
ABI.BR Yearly LT Debt VS Equity VS FCFABI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.3 Liquidity

ABI has a Current Ratio of 0.70. This is a bad value and indicates that ABI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ABI (0.70) is worse than 88.46% of its industry peers.
ABI has a Quick Ratio of 0.70. This is a bad value and indicates that ABI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.54, ABI is doing worse than 65.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.54
ABI.BR Yearly Current Assets VS Current LiabilitesABI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

5

3. Growth

3.1 Past

ABI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.61%, which is quite good.
The Earnings Per Share has been decreasing by -1.83% on average over the past years.
The Revenue has been growing slightly by 0.65% in the past year.
ABI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.69% yearly.
EPS 1Y (TTM)9.61%
EPS 3Y4.79%
EPS 5Y-1.83%
EPS Q2Q%8.89%
Revenue 1Y (TTM)0.65%
Revenue growth 3Y3.25%
Revenue growth 5Y2.69%
Sales Q2Q%-2.15%

3.2 Future

ABI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.42% yearly.
The Revenue is expected to grow by 4.35% on average over the next years.
EPS Next Y4.12%
EPS Next 2Y8.45%
EPS Next 3Y12.23%
EPS Next 5Y11.42%
Revenue Next Year2.16%
Revenue Next 2Y3.77%
Revenue Next 3Y3.89%
Revenue Next 5Y4.35%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABI.BR Yearly Revenue VS EstimatesABI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B 80B
ABI.BR Yearly EPS VS EstimatesABI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.94 indicates a correct valuation of ABI.
73.08% of the companies in the same industry are more expensive than ABI, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.48. ABI is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 14.95, which indicates a correct valuation of ABI.
ABI's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of ABI to the average of the S&P500 Index (34.04), we can say ABI is valued rather cheaply.
Industry RankSector Rank
PE 16.94
Fwd PE 14.95
ABI.BR Price Earnings VS Forward Price EarningsABI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ABI is valued a bit cheaper than 69.23% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ABI is valued a bit cheaper than 76.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.69
EV/EBITDA 8.28
ABI.BR Per share dataABI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABI does not grow enough to justify the current Price/Earnings ratio.
ABI's earnings are expected to grow with 12.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.11
PEG (5Y)N/A
EPS Next 2Y8.45%
EPS Next 3Y12.23%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.36%, ABI has a reasonable but not impressive dividend return.
ABI's Dividend Yield is slightly below the industry average, which is at 2.85.
With a Dividend Yield of 1.36, ABI pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.36%

5.2 History

The dividend of ABI decreases each year by -12.03%.
Dividend Growth(5Y)-12.03%
Div Incr Years3
Div Non Decr Years4
ABI.BR Yearly Dividends per shareABI.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

45.64% of the earnings are spent on dividend by ABI. This is a bit on the high side, but may be sustainable.
DP45.64%
EPS Next 2Y8.45%
EPS Next 3Y12.23%
ABI.BR Yearly Income VS Free CF VS DividendABI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
ABI.BR Dividend Payout.ABI.BR Dividend Payout, showing the Payout Ratio.ABI.BR Dividend Payout.PayoutRetained Earnings

ANHEUSER-BUSCH INBEV SA/NV

EBR:ABI (8/8/2025, 7:00:00 PM)

53.02

+0.58 (+1.11%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners19.76%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap102.76B
Analysts83.75
Price Target73.86 (39.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.36%
Yearly Dividend1.18
Dividend Growth(5Y)-12.03%
DP45.64%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.01%
Min EPS beat(2)5.76%
Max EPS beat(2)20.27%
EPS beat(4)4
Avg EPS beat(4)10.29%
Min EPS beat(4)4.3%
Max EPS beat(4)20.27%
EPS beat(8)8
Avg EPS beat(8)6.77%
EPS beat(12)10
Avg EPS beat(12)7.21%
EPS beat(16)13
Avg EPS beat(16)7.45%
Revenue beat(2)1
Avg Revenue beat(2)0.19%
Min Revenue beat(2)-4.2%
Max Revenue beat(2)4.57%
Revenue beat(4)2
Avg Revenue beat(4)-0.03%
Min Revenue beat(4)-4.2%
Max Revenue beat(4)4.57%
Revenue beat(8)2
Avg Revenue beat(8)-1.53%
Revenue beat(12)4
Avg Revenue beat(12)-1.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.4%
PT rev (1m)1.21%
PT rev (3m)4%
EPS NQ rev (1m)0.61%
EPS NQ rev (3m)0.61%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 16.94
Fwd PE 14.95
P/S 2
P/FCF 10.69
P/OCF 7.95
P/B 1.53
P/tB N/A
EV/EBITDA 8.28
EPS(TTM)3.13
EY5.9%
EPS(NY)3.55
Fwd EY6.69%
FCF(TTM)4.96
FCFY9.35%
OCF(TTM)6.67
OCFY12.58%
SpS26.49
BVpS34.67
TBVpS-32.03
PEG (NY)4.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 7.48%
ROCE 8.91%
ROIC 6.49%
ROICexc 6.95%
ROICexgc 96.58%
OM 25.87%
PM (TTM) 9.8%
GM 55.25%
FCFM 18.73%
ROA(3y)2.69%
ROA(5y)2.17%
ROE(3y)7.38%
ROE(5y)6.2%
ROIC(3y)6.05%
ROIC(5y)5.66%
ROICexc(3y)6.43%
ROICexc(5y)6.06%
ROICexgc(3y)81%
ROICexgc(5y)72.75%
ROCE(3y)8.3%
ROCE(5y)7.79%
ROICexcg growth 3Y11.31%
ROICexcg growth 5Y15.72%
ROICexc growth 3Y4.65%
ROICexc growth 5Y2.73%
OM growth 3Y-0.42%
OM growth 5Y-3.7%
PM growth 3Y4.44%
PM growth 5Y-10.98%
GM growth 3Y-1.3%
GM growth 5Y-1.99%
F-Score8
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 6.45
Debt/EBITDA 3.37
Cap/Depr 69.68%
Cap/Sales 6.46%
Interest Coverage 4.24
Cash Conversion 71.67%
Profit Quality 191.15%
Current Ratio 0.7
Quick Ratio 0.54
Altman-Z 1.72
F-Score8
WACC5.96%
ROIC/WACC1.09
Cap/Depr(3y)85.67%
Cap/Depr(5y)89.39%
Cap/Sales(3y)7.73%
Cap/Sales(5y)8.33%
Profit Quality(3y)163.01%
Profit Quality(5y)238.24%
High Growth Momentum
Growth
EPS 1Y (TTM)9.61%
EPS 3Y4.79%
EPS 5Y-1.83%
EPS Q2Q%8.89%
EPS Next Y4.12%
EPS Next 2Y8.45%
EPS Next 3Y12.23%
EPS Next 5Y11.42%
Revenue 1Y (TTM)0.65%
Revenue growth 3Y3.25%
Revenue growth 5Y2.69%
Sales Q2Q%-2.15%
Revenue Next Year2.16%
Revenue Next 2Y3.77%
Revenue Next 3Y3.89%
Revenue Next 5Y4.35%
EBIT growth 1Y5.98%
EBIT growth 3Y2.81%
EBIT growth 5Y-1.1%
EBIT Next Year40.75%
EBIT Next 3Y16.41%
EBIT Next 5Y12.43%
FCF growth 1Y29.73%
FCF growth 3Y6.91%
FCF growth 5Y4.78%
OCF growth 1Y13.49%
OCF growth 3Y0.57%
OCF growth 5Y1.41%